Korea Investment Corp Discloses Major New Stakes in Five U.S. Companies

Korea Investment CORP opened a new stake in The Boeing Company during Q2 by purchasing 412,428 shares worth about $89.28 million, indicating a sizable industrials exposure in its new positions.
KI Corp also established a new position in Welltower Inc., acquiring 895,149 shares for roughly $203.17 million, reflecting a substantial allocation to the REIT sector.
The utility sector is represented by a new stake in Southern Company, with 756,114 shares purchased for about $72.37 million, adding to KI Corp’s diversified utilities exposure.
Howmet Aerospace also became a new KI Corp holding, with 291,625 shares bought for roughly $78.41 million, contributing to the fund’s industrials and aerospace exposure.
Alnylam Pharmaceuticals was purchased in 247,660 shares for about $74.55 million, marking another life sciences position in KI Corp’s expanding multi-sector strategy.
Korea Investment Corp, a major institutional investor, is on an aggressive global buying spree. The fund disclosed new stakes in five U.S. companies during the second quarter, deploying nearly $518 million across industrials, real estate, utilities, aerospace, and pharmaceuticals. The moves signal a broad diversification strategy aimed at balancing growth with stability Watchlist News.
Korea Investment Corp invested $89.28 million in The Boeing Company during Q2, purchasing 412,428 shares Watchlist News. The move marks a significant wager on aerospace recovery. Boeing faces challenges but remains a key industrials play for major institutional investors seeking exposure to manufacturing and defense sectors.
The fund's largest new position landed in Welltower Inc., a real estate investment trust. Korea Investment Corp acquired 895,149 shares worth roughly $203.17 million Ticker Report. Welltower manages healthcare properties and senior housing. The $203 million bet reflects institutional confidence in the REIT sector's cash-generating power.
Korea Investment Corp also added utilities and aerospace to its portfolio mix. The fund bought 756,114 shares of Southern Company for $72.37 million, betting on steady dividend income Watchlist News. Meanwhile, Howmet Aerospace received a $78.41 million investment with 291,625 shares purchased. Both moves underscore KI Corp's focus on defensive, cash-heavy sectors Ticker Report.
Korea Investment Corp made its move into life sciences with a $74.55 million stake in Alnylam Pharmaceuticals. The fund purchased 247,660 shares of the biotech firm Watchlist News. Alnylam develops RNA interference drugs for rare genetic diseases. The investment shows KI Corp balancing slower utilities and industrials with higher-growth pharmaceutical exposure.
Publishers
14
Articles
19
Reach
33